The US Patent and Trademark Office’s position that after six years without a substantive challenge to validity a patent owner rightfully forms a “settled expectation” that their asset is inter partes review-pr... (more story)

A rule change in 2022 may have blunted Judge Alan Albright’s outsized impact on the domestic patent landscape, but the former Bracewell LLP partner has continued to preside over some of the most consequential ... (more story)

What was once a niche product is moving into the mainstream as companies that depend heavily on their patent portfolios drive demand for defensive patent insurance, a trend that insurers attribute in part to r... (more story)

Tech companies asked the EU to exclude standard-essential patents from customs enforcement, warning that border measures are ill-suited to complex licensing disputes and could bypass EU rules on good-faith neg... (more story)

The US Supreme Court is set to hear oral arguments in Hikma Pharmaceuticals v. Amarin Pharma next week over what constitutes induced patent infringement for generic medications sold with a so-called “skinny la... (more story)

Japan’s draft code on generative AI transparency and intellectual property has exposed a clear divide between rights holders seeking enforceable safeguards and AI developers warning of impractical disclosure o... (more story)

China is sharpening one of its most potent tools in intellectual property enforcement, moving to make punitive damages more predictable and more punishing for bad-faith infringers.

Overlapping name changes by two prominent animal welfare advocacy groups have sparked litigation over the exclusive right to use “humane society.” For nonprofits operating in a crowded field, the case undersco... (more story)